UNITED STATES OF AMERICA, EX REL. ROBERT A. CUTLER v. THE CIGNA GROUP.

CourtDistrict Court, M.D. Tennessee
DecidedAugust 2, 2022
Docket3:21-cv-00748
StatusUnknown

This text of UNITED STATES OF AMERICA, EX REL. ROBERT A. CUTLER v. THE CIGNA GROUP. (UNITED STATES OF AMERICA, EX REL. ROBERT A. CUTLER v. THE CIGNA GROUP.) is published on Counsel Stack Legal Research, covering District Court, M.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
UNITED STATES OF AMERICA, EX REL. ROBERT A. CUTLER v. THE CIGNA GROUP., (M.D. Tenn. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF TENNESSEE NASHVILLE DIVISION

UNITED STATES OF AMERICA ex rel. ) ROBERT A. CUTLER, ) ) NO. 3:21-cv-00748 Plaintiff, ) ) JUDGE RICHARDSON v. ) ) CIGNA CORP. et al., ) ) Defendants. )

MEMORANDUM OPINION Pending before the Court is the United States’ Motion to Partially Intervene (Doc. No. 157, “Motion”), which is supported by an accompanying Memorandum of Law (Doc. No. 158, “Government’s Memorandum”). Via the Motion, and pursuant to 31 U.S.C. § 3730(c)(3), the United States (“the Government”) seeks to intervene as to some of the claims in this False Claims Act case, which were brought by Relator Robert A. Cutler on the Government’s behalf—namely, all of Relator’s claims as to which it did not expressly decline to intervene by the intervention deadline. Defendants have filed a response opposing the Motion (Doc. No. 161, “Response in Opposition”).1 In their Response in Opposition, Defendants provide a helpful summary of relevant background information, of Relator’s factual allegations, and of the procedural background of the instant case as a whole and of the instant Motion in particular

1 The pagination in the Response in Opposition differs (by a page) from the pagination added by the Clerk’s Office (“Page __ of __”) as part of the pagination process associated with Electronic Case Filing. Herein, the Court endeavors to use the Clerk’s Office’s pagination rather than Defendants’ pagination. Established by Part C of the Medicare Act, Medicare Advantage (“MA”) is a public private program that allows eligible individuals to receive government- subsidized health benefits through private insurance plans. See 42 U.S.C. § 1395w- 21 et seq. Under that program, MA organizations (“MAOs”) like Cigna contract with the Centers for Medicare and Medicaid Services (“CMS”) to manage the care and bear the financial risk for the beneficiaries who enroll in their plans. In exchange, they receive monthly per-member payments, which are adjusted up or down based on members’ demographic characteristics and health status relative to the average Medicare beneficiary. Id. § 1395w-23(a)(1). To perform that payment analysis—a process known as “risk adjustment”—CMS requires MAOs to submit diagnostic data from covered medical encounters that a member has with a provider. See 42 C.F.R. § 422.310. This case concerns data from a narrow set of patient encounters as part of Cigna’s 360 Program, through which Cigna’s MA plan members receive annual comprehensive health risk assessments conducted by their primary care provider (“PCP”) in the PCP’s office or, less frequently, by nurse practitioners in the patient’s home. The Medicare population enrolled in MA plans includes members who are homebound and may not see their PCP in a given year for various reasons, including limited mobility or lack of transportation. In such circumstances, inhome 360 exams may help ensure that members are seen at least once a year by a licensed provider who reviews their medical history and current symptoms, conducts a physical exam, and evaluates their medications and any other information obtained during the visit. Diagnostic data from 360 exams is submitted to CMS. To promote follow-up care from in-home exams, the 360-exam form itself is also sent to the PCP. CMS has long scrutinized diagnostic data from in-home exams and expressly permits MAOs to submit it for risk-adjustment purposes. Well before Relator filed this qui tam action, the same allegations he makes here had been leveled by others against the entire MA industry. See Medicare Payment Advisory Commission, Report to Congress 347-50 (Mar. 2016) (describing concerns that in-home exams are performed by “nurse practitioner[s]” hired by “third-party vendors” “solely as a diagnosis-collection vehicle,” including for conditions that “cannot be accurately identified with equipment brought into the patient’s home”). In the face of those public allegations, CMS has extensively considered and repeatedly rejected proposals to exclude data from in-home exams for risk-adjustment purposes. To the contrary, it has recognized that such exams “can have significant value as care planning and care coordination tools,” and has explained that “[i]n the home setting, the provider has access to more information than is available in a clinical setting.” CMS, Announcement of Calendar Year (CY) 2016 Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter 145 (April 6, 2015), https://go.cms.gov/3rNlwL9. Indeed, as recently as July 2020, in response to a report highlighting payments for diagnoses of the very conditions at issue from in- home health risk assessments, CMS reiterated that it accepts those diagnoses “for risk adjustment” and that such assessments “are a tool for early identification of health risks to improve beneficiaries’ health outcomes.” CMS Comments 38-40, https://oig.hhs.gov/oei/ reports/OEI-03-17-00471.pdf. On October 2, 2017, Relator filed this qui tam action under seal in the Southern District of New York, and it was assigned to Judge Karas. Dkt. 94. Under the FCA, that triggered the 60-day period for the government to investigate and determine whether to take control of the litigation or allow Relator to prosecute the case on the United States’ behalf. See 31 U.S.C. § 3130(b)(2), (4). At that time, Relator was general counsel of a former 360 Program vendor that had initiated a contentious arbitration action against Cigna involving a dispute about contractual payment terms. Relator’s Amended Complaint repackages generic concerns CMS has long heard and rejected with respect to in-home exams, asserting three discernable FCA theories: (1) the diagnoses that Cigna reported to CMS for payment were allegedly identified during home visits designed to be “a data- gathering exercise rather than a legitimate medical encounter,” where the provider was “prohibited” from “providing medical care”; (2) the diagnoses allegedly were for certain conditions that “could not have been treated or assessed during 360 visits”; and (3) the diagnoses allegedly “lacked medical-record support or otherwise violated CMS coding rules.” Dkt. 12, ¶ 47. The government, then represented only by the U.S. Attorney’s Office for the Southern District of New York, was granted more than 26 months’ worth of extensions beyond the 60-day statutory period—the better part of two and a half years altogether—to conduct its investigation. During that time, Cigna cooperated fully, producing more than 110,000 documents totaling more than 2.6 million pages. Those materials covered, among other things: Cigna’s contracts with its vendors; 360 Program policies, presentations, training materials, and exam forms for use in connection with in-home exams by vendors; documents and communications regarding the Program’s structure and design; and communications within Cigna and with vendors regarding the Program. Those productions were made on a rolling basis beginning in October 2018 and were completed by August 2019. In addition, Cigna made three witnesses available for depositions, including a 30(b)(6) representative whom the government deposed in June 2019. Although Cigna scheduled two other employees for requested depositions in September 2019, the government asked to reschedule them for a month later and then, shortly after that request, postponed the remaining depositions indefinitely.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States Ex Rel. Hall v. Schwartzman
887 F. Supp. 60 (E.D. New York, 1995)
D.T. v. Sumner Cty. Sch.
942 F.3d 324 (Sixth Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
UNITED STATES OF AMERICA, EX REL. ROBERT A. CUTLER v. THE CIGNA GROUP., Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-ex-rel-robert-a-cutler-v-the-cigna-group-tnmd-2022.